Gland Pharma Ltd Quarterly Result
Gland Pharma Ltd
NSE: GLAND
Net Profit - Last Quarter
Gland Pharma Ltd Quarterly Results Key Highlights
- The revenue of Gland Pharma Ltd for the Mar '26 is ₹ 1854 crore as compare to the Dec '25 revenue of ₹ 1758 crore.
- This represent the growth of 5.44% The ebitda of Gland Pharma Ltd for the Mar '26 is ₹ 624.49 crore as compare to the Dec '25 ebitda of ₹ 473.7 crore.
- This represent the growth of 31.83% The net profit of Gland Pharma Ltd for the Mar '26 is ₹ 366.68 crore as compare to the Dec '25 net profit of ₹ 261.48 crore.
- This represent the growth of 40.23%.
Gland Pharma Ltd Quarterly Results Analysis
Market Price of Gland Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 29 Jul 2026 | 2544.15 |
| 28 Jul 2026 | 2427.25 |
| 27 Jul 2026 | 2427.8 |
| 24 Jul 2026 | 2378.35 |
| 23 Jul 2026 | 2377.55 |
| 22 Jul 2026 | 2440.25 |
| 21 Jul 2026 | 2484.35 |
| 20 Jul 2026 | 2459.5 |
| 17 Jul 2026 | 2449.75 |
| 16 Jul 2026 | 2533 |
Historical Revenue of Gland Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Gland Pharma Ltd
Historical EBITDA of Gland Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Gland Pharma Ltd
Historical Net Profit of Gland Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Gland Pharma Ltd
Gland Pharma Ltd News Hub
Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr
Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before tax (PBT) s
Read more
07 Aug 24
Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter
Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 2024 as agai
Read more
06 Aug 24
US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility
The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspection was c
Read more
05 Aug 24
Gland Pharma Ltd gains for third straight session
Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 1936.35, up 1
Read more
09 Sept 24
Popular Search
About Gland Pharma Ltd
- Gland Pharma Limited was incorporated as Gland Pharma Private Limited', a private limited company on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
- Subsequently, the name of the Company was changed to Gland Pharma Limited' and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
- The Company is primarily engaged in manufacturing injectable formulations. Established in Hyderabad, India, Company has evolved into a prominent entity in the global generic injectables market, with operations extending to over 60 countries including the United States, Europe, Canada, Australia, and India.
- Primarily functioning under a B2B model, the company provides comprehensive services such as contract development, dossier compilation, technology transfer, and manufacturing across various delivery systems.
FAQs for Quarterly Results of Gland Pharma Ltd
What key financial metrics are included in Gland Pharma Ltd's quarterly results?
When does Gland Pharma Ltd announce its quarterly results?
How does Gland Pharma Ltd's quarterly performance impact its stock price?
What is the impact of Gland Pharma Ltd's quarterly results on dividends?
Are there any special announcements usually made during Gland Pharma Ltd's quarterly results?
